This paper describes an improved method for the in vitro detection of antibodies specifically directed against human cytomegalovirus (CMV)-induced membrane antigens present on the surface of CMV-infected fibroblasts (CMV-MA). Viable cells were found to be essential for specific visualization of CMV-MA staining. The addition of divalent cations (2.6 mM Ca2' and 2.2 mM Mg2+) and glucose (180 mM) to the incubation and washing buffers improved the viability and morphology of the cells and increased the cell yield at the end of the assay. Clustering of antigen-antibody complexes on the surface of viable CMV-infected cells was prevented by low-temperature incubation (0 to 4°C) rather than by the addition of agents which act on the metabolism of the cell. No interaction with the CMV-induced Fc receptor was observed at 0°C with either human sera or murine monoclonal antibodies. The specificity of the CMV-MA reaction was confirmed by using monoclonal antibodies to CMV nuclear, cytoplasmic, and membrane-associated antigens. Furthermore, a microplate modification of the membrane fluorescence test is described which is suitable for multisample screening purposes. This method can be applied to the determination of anti-CMV-MA antibody titers in human sera and to the screening of hybridoma supernatants for the presence of antibodies with specificity for CMV-MA.
The immunological recognition of cytomegalovirus (CMV)-induced membrane antigens exposed on the surface of infected cells (CMV-MA) may contribute to the recovery from CMV infection in the human host (2, 14, 15, 19) . Humoral immune responses to CMV-MA may be of special importance in patients with iatrogenically suppressed cellular immunity, but they have been studied only incidentally (2, 15, 16, 26) . At present, little is known about the molecular nature of antigens involved in the immunological recognition of the CMV-MA complex. The use of well-defined human sera (3, 13, 23) and monoclonal antibodies with specificity for CMV-MA may allow the characterization of these CMV antigens (1, 17, 18 ; J. M. Middeldorp, L. de Leij, and T. H. The, Abstr. 6th Cold Spring Harbor Symp. Herpesviruses, p. 145, 1982) . For these studies, a convenient method is required that allows the analysis of multiple samples for the presence of antibodies with specificity for CMV-MA. Indirect immunofluorescence and immunoperoxidase staining of viable (1, 3, 5, 13, 16, 17, 22, 23, 26) or air-dried (8) CMV-infected cells have been used to measure antibody binding to CMV-MA. However, the specificity of the membrane staining reaction was not always reported (1, 5, 8, 16, 17) . The use of viable CMV-infected cells is complicated by virus-induced cytopathology. In addition, damage of cell membranes may introduce false-positive staining of intracellular cytoplasmic and even nuclear antigens, as has been demonstrated for varicella-zoster virus (22, 27) . The presence of CMV-induced receptors with specificity for human immunoglobulin G (IgG) in and on the infected cell may introduce yet another factor leading to false-positive results (7, 21) .
In the present study, we analyzed and modified existing procedures to improve the visualization of specific CMV-MA staining. We used anti-32-microglobulin (P2M) fluorescence as the reference for specific membrane staining, since * (13) . Uninfected subconfluent FF monolayers were used as controls. In some instances, as indicated in the text, before immunofluorescence the cells were mildly fixed with paraformaldehyde (1%) or glutaraldehyde (0.025%) in PBS for 3 to 5 min and washed subsequently in PBS once more or were air dried following trypsinization by the method of Haikin and Sarov (8) . Cells thus pretreated were further processed at room temperature. Membrane immunofluorescence. All handlings and incubations were performed on ice with precooled solutions unless stated otherwise. Prior to immunofluorescence, infected cell monolayers were placed on ice and carefully washed with ice-cold Hanks balanced salt solution containing 2.6 mM Ca2+, 2.2 mM Mg2+, 180 mM glucose, and 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) (pH 7.4) (HH). Subsequently, appropriate dilutions (in HH) of human sera or hybridoma supernatants were added and incubated for 1 h. Following two washes with HH, fluorescein isothiocyanate-labeled second antibodies were added. Fluorescein isothiocyanate-labeled rabbit F(ab')2 fragments with specificity for human IgM or IgG (heavy chain) were prepared as previously described (13, 24) . Goat anti-mouse and swine anti-rabbit conjugates were purchased from Nordic Immunological Laboratories, Tilburg, The Netherlands, and Dakopatts, Copenhagen, Denmark, respectively. After 1 h, the cells were washed three times with HH, subsequently fixed with methanol at -20°C for 20 min, and air dried. Glass slides were mounted in 50% glycerol-PBS (pH 8.0), and 96-well plates were stored dry in the dark at 4°C and received 1 drop of 50% glycerol-PBS per well prior to reading.
Glass slides were examined by using a Leitz Dialux fluorescence microscope equipped with Ploem opaque epiillumination, and 96-well plates were read by using a Leitz Diavert inverted fluorescence microscope with a long-focus (optic specification, L 32 x 0.60) objective lens (10, 11).
Modifications of this procedure used for the determination of optimal staining conditions consisted of incubation at elevated temperatures (room temperature or 37°C), incubation in the presence of 0.1 M sodium azide, or substitution of HH by PBS. Membrane fluorescence was also performed with cells in suspension at 0°C immediately following (i) trypsinization, (ii) harvesting in PBS containing 10 mM EDTA, or (iii) harvesting in complete medium containing 12 mM lidocaine (20) .
Sera and CMV serology. Sera containing anti-CMV-MA antibodies were obtained from patients who had a recent active CMV infection, manifesting either as CMV mononucleosis in previously healthy persons or as posttransplantation CMV infection in renal allograft recipients (15) . Furthermore, sera were obtained from healthy individuals as either seropositive or seronegative for CMV. CMV serology was determined by an enzyme-linked immunosorbent assay (ELISA) (12) and indirect immunofluorescence on acetonefixed targets (25) . Purified rabbit IgG anti-N2M antibodies were purchased from Dakopatts.
Monoclonal antibodies. BALB/c mice were immunized twice with sucrose gradient-purified (14; Middeldorp et al., 6th Cold Spring Harbor Symp.) membrane fragments isolated from CMV-infected cells showing 100% cytopathic effects or with whole CMV-infected cells. Three days after an intravenous booster injection, splenic lymphocytes were fused with the P3-X63/Ag8 murine myeloma cell line (6) . After hybrid selection, the cells were grown until small colonies were visible, and the supernatants were subsequently analyzed by membrane fluorescence or by a CMV ELISA as described above. Hybridomas producing CMVspecific antibodies were cloned and used for further studies (Table 1; 11) . Detailed studies with these monoclonal antibodies will be published elsewhere. Antibodies CH12 and CH16-1 were a gift from L. Pereira. They reacted with CMV glycoproteins gC and gD, mainly associated with the nuclear and cytoplasmic fractions of CMV-infected cells (17, 18) . Rabbit IgG to a purified CMV glycoprotein of 64 kilodaltons (kDa) was kindly provided by J. A. Zaia (28) . All monoclonal antibodies were negative in Epstein-Barr, herpes simplex, and varicella-zoster virus-infected cells, and antibody 4-4-13 
RESULTS

Preparation of cells for membrane immunofluorescence.
Mild fixation of the cells prior to immunofluorescence with 1% paraformaldehyde or 0.025% glutaraldehyde in PBS at 0°C induced cytoplasmic and nuclear (inclusion body) staining with anti-CMV sera, while the reaction for P2M remained restricted to the cell membrane on fixed cells (data not shown).
Air-dried CMV-FF showed a comparable staining pattern for both the anti-P2M and anti-CMV reactions, although the staining pattern was rather diffuse (Fig. 1A and B) . CMV-FF suspended by trypsinization showed a decrease in the anti-P2M and anti-CMV staining reactions when compared with suspended cells without the use of proteolytic enzymes, e.g., by using 10 mM EDTA in PBS or 12 mM lidocaine in complete medium. This result indicated that membrane antigens were (partly) removed by trypsinization, as used in experiments reported in reference 8. On the other hand, CMV-MA staining on viable CMV-FF at 4°C (see below) resulted in a specific staining of the cell boundaries (Fig. 2) .
A more extended comparison of CMV-MA reactions on air-dried and viable CMV-infected cells ( (Fig. 1D ), but only three of the antisera were reactive with the membranes of viable cells. Furthermore, the antibody titer against CMV-MA on air-dried cells was related to the antibody titer against CMV late nuclear antigens (CMV-LA), whereas the antibody titer against CMV-MA on viable cells was not ( tested by trypan blue exclusion). These factors caused a great reduction in the number of cells suitable for evaluation of fluorescence staining. The recovery of CMV-FF with good morphology and viability was improved by replacing PBS with HH in washes and serum-conjugate dilutions. In addition, gentle pipetting of fluids onto CMV-FF monolayers also improved the cell yield. These modifications allowed better judgment of membrane staining patterns for either the anti-N2M or the anti-CMV reaction.
To prevent antigen capping, we studied the effect of temperature, because the chemical reagent sodium azide reduced cell adhesion and caused subsequent cell loss in both infected and uninfected monolayers. Incubation without sodium azide at room temperature or, even more, at 37°C induced patch and cap formation and internalization of aggregated complexes. This led to a rather blurred and coarsely speckled staining pattern, similar to that shown in Fig. 1A and B. Incubation on ice combined with washes in cold buffers (4°C) revealed membrane antigens as a smooth rim of fluorescence staining along the cell lining (Fig. 2 ). An additional advantage of the low-temperature protocol was the reduction of nonspecific (cytoplasmic and membrane) staining of both CMV-seropositive and CMV-seronegative human sera. This reduction of nonspecific staining allowed a much better discrimination between positive and negative reactions (see below).
Stage and CMV infection of the target cells. FF incubated for 72 to 96 h after inoculation with 1 to 2 PFU of CMV per cell provided the best targets for the detection of anti-CMV-MA antibodies. At this stage of infection, CMV-FF displayed CMV late membrane antigens (13) , and CMVinduced cytopathology was less pronounced than at early (6 to 24 h p.i.) and very late (>120 h p.i.) stages of CMV infection, resulting in improved morphology and increased cell yield at the end of the assay (usually about 60 to 80%). Cells incubated for 24 or 48 h failed to react with a considerable number of sera that were positive for cells incubated for 72 to 96 h, as was recently shown (13) . Cells incubated for >120 h were unsuitable because of advanced cytopathology and cell death, making them highly permeable for anti-CMV antibodies, thus causing nonspecific fluorescence. Specificity of CMV-MA staining. No evidence was found for the binding of human immunoglobulins to the CMVinduced Fc receptor when membrane fluorescence was performed at 0°C. Sera from CMV-seronegative donors were uniformly negative, even though most of them contained antibodies to other human herpesviruses (data not shown). Sera from healthy CMV-seropositive donors (n = 25) were generally negative on viable CMV-FF cells (Tables 2 and 3) , even in the presence of high antibody titers against CMV intracellular antigens ( Fig. 1C and D) . Using heavy-chainspecific, fluorescein isothiocyanate-labeled second antibodies, we found IgG and IgM to CMV-MA in sera from patients with a recent symptomatic CMV infection ( Fig. 2A to C) .
CMV-MA-specific IgM (Fig. 2B) was often found early after the onset of symptoms together with low ( Fig. 2A) or no IgG to CMV-MA. The latter developed with some delay (Fig.  2C) , especially in patients with primary CMV infection.
The specificity of the CMV-MA reaction was further established by using monoclonal antibodies with defined specificities for CMV nuclear, cytoplasmic, and membrane antigens (Table 1 and Fig. 3 and 4 ). Monoclonal antibodies with specificities for CMV nuclear antigens were all negative by membrane fluorescence (Fig. 3) . One of two antibodies with a specificity for Golgi region-associated CMV antigens showed a slightly positive reaction on viable cells (Table 1) . Monoclonal antibodies with specificities for CMV-MA (7C1, 13D2, and 1-3-2; Table 1 ) showed reactions with CMV cytoplasmic and membrane antigens on fixed CMV-FF cells (Fig. 4B and D) and a clear membrane lining on viable CMV-FF cells (Fig. 4A and C) . The reactivity of these anti-CMV-MA monoclonal antibodies was clearly restricted to CMV-infected cells, as shown by plaque staining in Fig.  4E and F. Monoclonal antibody CH16-1, detecting CMV glycoprotein gD (CMV glycoprotein nomenclature was adapted from Pereira et al. [17] ) and previously considered to react with the plasma membrane (17), was negative in our assay but reacted strongly with the nuclei of fixed infected cells (comparable to antibody 1-5-12; Fig. 3D ). This result was recently confirmed (18) . Antibodies to CMV glycoprotein gC (66 kDa), both monoclonal and polyclonal, were also negative and showed nuclear and cytoplasmic fluorescence VOL. 24, 1986 on January 20, 2018 by guest patterns on fixed infected cells (comparable to antibody 1-5-17; Fig. 3C ).
Microplate modification. The microplate procedure described in Materials and Methods allows the evaluation of about 600 samples on CMV-infected and uninfected FF in a single day, with a requirement of only 25 ,u per test sample. The use of a multichannel pipette further simplifies the procedure.
Although the optical quality of tissue culture plastics is poorer than that of glass slides, immunofluorescence patterns can easily be read by using an inverted microscope equipped with a long-focus objective lens (Fig. 5) . Twelve sera from CMV-infected patients were analyzed on glass slides and microplates for IgG and IgM against CMV-MA in serial twofold dilutions starting at 1:20. Identical results were found for IgG and IgM in 10 and 11 cases, respectively. The microplate method missed one weakly positive (1:20) IgG reaction, and two sera had a twofold-reduced endpoint titer (one for IgG and one for IgM).
In the production of monoclonal antibodies against CMV-MA, a comparison of microplate and glass slide immunofluorescence for the screening of culture supernatants J. CLIN. MICROBIOL. 
DISCUSSION
The results from this study indicate that only viable CMV-infected cells are suitable for the detection of antibodies against CMV-MA. However, particular measures are required to ensure the specificity of the CMV-MA reaction.
In human sera anti-CMV antibodies are mainly directed against CMV intracellular (nuclear and cytoplasmic) antigens (Fig. 1D) , and the sera may contain only small amounts of antibodies with specificity for CMV-MA (2, 5, 13, 15, 16, 26) . Using human sera, we found that even mild fixation of CMV-infected cells prior to immunofluorescence causes considerable damage to the cell membranes, thereby making CMV intracellular (including nuclear) antigens accessible to their corresponding antibodies. The observed intracellular fluorescence prevents a proper analysis of specific membrane staining.
At first glance, air-dried cells appeared to be a proper substrate for the detection of anti-CMV-MA antibodies (cf. Fig. 1A and B) , as suggested by Haikin and Sarov (8) .
However, more extended evaluation of the specificity of the membrane immunofluorescence reaction (Tables 2 and 3) indicated that this was not so. In fact, membrane antigens were (partly) removed by trypsinization prior to membrane immunofluorescence (8), a result which has also been observed for varicella-zoster virus-infected cells (29) . Therefore, we suggest that, although membrane antigens are apparently detected, the membrane staining technique as described by Haikin and Sarov (8) predominantly detects antibodies directed against CMV intracellular antigens, which are accessible through membranes ruptured by the drying procedure. This may explain the observed correlation between membrane immunofluorescence and complement fixation (8) and membrane immunofluorescence on air-dried cells and the ELISA (Table 3) (13) . Thus, the observed fluorescence staining pattern was more directly related to the original distribution of antigens over the cell membrane (13) . This result is in agreement with the results of Huet et al. (9) who showed, by anti-132M fluorescence and electron microscopy, that elevation of the temperature above 0°C rapidly led to aggregation of 2M-anti-P2M complexes in the plane of the membrane, followed by subsequent internalization of the aggregated complexes.
An additional advantage of incubation at low temperatures was the reduction of nonspecific staining. The nonspecific staining with human sera observed at elevated temperatures may be caused by binding to the CMV-induced Fc receptor (6, 21) or by penetration of antibodies directed against CMV intracellular antigens or both. These reactions are apparently minimal at 0°C.
The CMV-induced Fc receptor is described as being specific for human IgG at 37°C (7, 21 (14) .
Recently, a microtiter system was introduced for the detection of antinuclear antibodies (10) ; this system has also been applied to the detection of human antibodies to Epstein-Barr virus nuclear antigens (11 
